PCM Encore’s CME Group CME Stock Holding History

PCM Encore’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$531K	Sell	2,406 -255	-10%	-$70.5K	0.09%	204
2026 Q1	$786K	Buy	2,661 +105	+4%	+$31.2K	0.16%	126
2025 Q4	$698K	Buy	+2,556	New	+$695K	0.15%	129

Other funds holding CME

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

PCM Encore's CME Position: Q2 2026 in Review

PCM Encore reduced its CME Group (CME) stake by 9.6% in Q2 2026, selling an estimated $70.5K and leaving 2,406 shares worth $531K. The position accounts for 0.09% of the portfolio, ranked #204.

PCM Encore first reported a position in CME in Q4 2025 and has held it in 3 quarters since. The position peaked at $786K in Q1 2026. 1,701 funds tracked by Wall St. Rank hold CME as of Q2 2026.

PCM Encore held 2,406 shares of CME Group worth $531K as of Q2 2026.
PCM Encore sold 255 CME Group shares in Q2 2026, an estimated $70.5K.
CME Group made up 0.09% of PCM Encore's portfolio in Q2 2026, its #204 holding.
PCM Encore first reported a position in CME Group in Q4 2025 and has held it in 3 quarters since.
PCM Encore's CME Group position peaked at $786K in Q1 2026.
1,701 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on PCM Encore's 13F filing for Q2 2026, filed 11 Aug 2026.